BMI1 Human shRNA Lentiviral Particle (Locus ID 648)

CAT#: TL314462V

BMI1 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Product Images

GFP signal was observed under microscope at 48 hours after transduction of TL314462A virus into HEK293 cells. TL314462A virus was prepared using lenti-shRNA TL314462A and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of TL314462B virus into HEK293 cells. TL314462B virus was prepared using lenti-shRNA TL314462B and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL314462C] virus into HEK293 cells. [TL314462C] virus was prepared using lenti-shRNA [TL314462C] and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL314462D] virus into HEK293 cells. [TL314462D] virus was prepared using lenti-shRNA [TL314462D] and TR30037 packaging kit.

Specifications

Product Data

• Locus ID: 648
• Synonyms: flvi-2/bmi-1; FLVI2/BMI1; PCGF4; RNF51
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: NM_005180, NM_005180.1, NM_005180.2, NM_005180.3, NM_005180.4, NM_005180.5, NM_005180.6, NM_005180.7, NM_005180.8, BC011652, BC011652.2, NM_005180.9
• UniProt ID: P35226
• Summary: This gene encodes a ring finger protein that is major component of the polycomb group complex 1 (PRC1). This complex functions through chromatin remodeling as an essential epigenetic repressor of multiple regulatory genes involved in embryonic development and self-renewal in somatic stem cells. This protein also plays a central role in DNA damage repair. This gene is an oncogene and aberrant expression is associated with numerous cancers and is associated with resistance to certain chemotherapies. A pseudogene of this gene is found on chromosome X. Read-through transcription also exists between this gene and the upstream COMM domain containing 3 (COMMD3) gene. [provided by RefSeq, Sep 2015]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).